Apex Biotechnology Corp. (1733)
Market Open
9 Jun, 05:30
TWSE TWSE Primary NT$
28. 65
-1.25
-4.1806%
NT$
3.07B Market Cap
- P/E Ratio
8% Div Yield
362,691 Volume
- Eps
NT$ 29.9
Previous Close Want to track 1733 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Apex Biotechnology Corp. (1733) Statistics
Valuation metrics
Market Cap 3.07B
Enterprise value 2.64B
Trailing P/E (ttm) 16.97
Forward P/E -
PEG ratio 1.3
Price/Sales (ttm) 1.62
Price/Book (mrq) 1.7
Enterprise Value/Revenue 1.39
Enterprise Value/EBITDA 12.8
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 264.93K
Average volume (90 days) 165.92K
Price summary
52-Week low 27
52-Week high 38.7
Beta -
50-Day moving average 29.26
200-Day moving average 29.82
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 1.2
Trailing annual dividend yield 0.039%
5-Year annual dividend yield -
Payout ratio 0.66
Dividend Date -
Ex-Dividend Date -
Last split factor 1:1
Last split Date 1 Jul 2009
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.1%
Operating margin 0.09%
Operational effectiveness
Return on assets 0.07%
Return on equity 0.1%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 18.97
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 1.82
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.65
Total debt (mrq) -
Total Debt/Equity (mrq) 0.09
Current ratio (mrq) 3.14%
Book value per share (mrq) 18.15
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
